AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7614523
Drug: Naproxen, 500
RxNorm normalized name: Naproxen, 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen, 500 mg twice daily
Trial: 2000833
Drug: High-sodium polymeric-glucose
RxNorm normalized name: glucose / sodium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-sodium polymeric-glucose solution (maltodextrins 18 g Glucidex 12/L + 2.5 g NaCl/L)
Trial: 2000833
Drug: Standard oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard oral rehydration solution
Trial: 6510015
Drug: 0.05% diflorasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05% diflorasone diacetate ointment, once a day
Trial: 6510015
Drug: 0.1% betamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% betamethasone valerate ointment, twice a day
Trial: 30481110
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) administration of MMRV vaccine
Trial: 30481110
Drug: Subcutaneous (SC)
RxNorm normalized name: immune globulin subcutaneous (human) - klhw Injection [Xembify]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous (SC) administration of MMRV vaccine
Trial: 1139387
Drug: Glycopyrrolate 0.2
RxNorm normalized name: glycopyrrolate 0.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate 0.2 mg
Trial: 22972032
Drug: Prednisone 15
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone 15 mg daily
Trial: 22972032
Drug: Prednisone 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 7.5 mg daily
Trial: 18046293
Drug: Propofol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (20 mg bolus and 1.0 mg x kg(‐1) x h(‐1) infusion)
Trial: 18046293
Drug: Midazolam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (1 mg bolus and 1.0 mg x h(‐1) infusion)
Trial: 7825408
Drug: Topical cyclosporin
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cyclosporin 2% in olive oil
Trial: 2449651
Drug: Gamma-globulin infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gamma-globulin infusion (GG)
Trial: 2449651
Drug: Aspirin only
RxNorm normalized name: Aspirin only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin only (Control)
Trial: 31236580
Drug: Objective measures
RxNorm normalized name: MEASLES VIRUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Objective measures for ocular and oral dryness
Trial: 17255296
Drug: New targeted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New targeted therapies
Trial: 26475054
Drug: Albuterol MDPI
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol MDPI (180 μg, 2 inhalations of 90 μg each)
Trial: 26831652
Drug: Albuterol MDPI
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol MDPI
Trial: 7898828
Drug: Esterified estrogens
RxNorm normalized name: Esterified Estrogens
DrugBank: Esterified estrogens (DB09381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esterified estrogens (1.25 mg) and methyltestosterone (2.5 mg) daily for 2 years
Trial: 7898828
Drug: Esterified estrogens
RxNorm normalized name: Esterified Estrogens
DrugBank: Esterified estrogens (DB09381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esterified estrogens (1.25 mg) daily for 2 years
Trial: 31017822
Drug: ACT017 (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACT017 (doses ranging from 62.5 to 2000 mg)
Trial: 27557937
Drug: Ferric pyrophosphate
RxNorm normalized name: Ferric Pyrophosphate
DrugBank: Ferric pyrophosphate citrate (DB13995)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferric pyrophosphate citrate (2.5, 5.0, 7.5, or 10 mg administered over 4 hours; 15 or 20 mg administered over 12 hours)
Trial: 29103664
Drug: Canagliflozin 100
RxNorm normalized name: canagliflozin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin 100 mg and 300 mg
Trial: 19791825
Drug: All new
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All new biological agents
Trial: 11316024
Drug: LASIK custom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LASIK custom treatment
Trial: 11316024
Drug: LASIK conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LASIK conventional treatment
Trial: 9397101
Drug: Misoprostol tablets
RxNorm normalized name: Misoprostol Tablets
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol tablets (n = 234)
Trial: 9397101
Drug: Misoprostol gel
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Misoprostol gel (n = 233)
Trial: 8248841
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy with wedge filter (group B)
Trial: 8248841
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy without wedge filter (group A)
Trial: 8248841
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy with wedge filter for large T1a lesions (group B)
Trial: 8248841
Drug: Radiation therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation therapy without wedge filter for large T1a lesions (group A)
Trial: 2884191
Drug: Penbutolol 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penbutolol 40 mg
Trial: 27576775
Drug: More intensive
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More intensive antiplatelet therapy (meta-analysis across 4 trials)
Trial: 22484638
Drug: Curcumin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (500 mg daily for 7 days)
Trial: 20845811
Drug: Panitumumab (single-agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Panitumumab (single-agent treatment)
Trial: 20845811
Drug: Cetuximab (single-agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetuximab (single-agent treatment)
Trial: 15892486
Drug: Homeopathic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Homeopathic treatment (5 globules in a potency of 200c given at 12h interval during ICU stay)
Trial: 9915448
Drug: L-arginine (1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (1,500 mg daily)
Trial: 7776995
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant therapy with INR between 2.0 and 3.9
Trial: 7776995
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant therapy with INR below 2.0
Trial: 7776995
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant therapy with INR of 5.0 or above
Trial: 2333695
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose penicillin
Trial: 31496678
Drug: Tiotropium/olodaterol combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium/olodaterol combination therapy
Trial: 31496678
Drug: Tiotropium monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium monotherapy
Trial: 26363637
Drug: Azithromycin (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (30 mg/kg weekly for up to 24 months)
Trial: 19846149
Drug: Doxazosin (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (0.03 mg/kg daily)
Trial: 31520576
Drug: Ibuprofen (control)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (control)
Trial: 17110825
Drug: Methylphenidate (OROS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (OROS MPH, Concerta) 18‐54 mg/d
Trial: 1451052
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of 5‐fluorouracil
Trial: 14740125
Drug: Additional administration
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional administration of leucovorin or levamisole
Trial: 14740125
Drug: Adjuvant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant therapy with new drugs (capecitabine, UFT, irinotecan, oxaliplatin)
Trial: 8674405
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg daily of tauroursodeoxycholic acid
Trial: 8674405
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg daily of tauroursodeoxycholic acid
Trial: 8674405
Drug: 1500 mg
RxNorm normalized name: inulin 1500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 mg daily of tauroursodeoxycholic acid
Trial: 1455418
Drug: Induced hypertension
RxNorm normalized name: INVESTIGATIONAL ANTI-HYPERTENSIVE DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induced hypertension chemotherapy (IHC) with 5‐fluorouracil, adriamycin, and mitomycin C
Trial: 1455418
Drug: Non-induced hypertension
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-induced hypertension chemotherapy (same regimen without hypertension)
Trial: 1455418
Drug: Induced hypertension
RxNorm normalized name: INVESTIGATIONAL ANTI-HYPERTENSIVE DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induced hypertension chemotherapy (IHC)
Trial: 6732937
Drug: Hydralazine (apressine)
RxNorm normalized name: hydralazine Oral Tablet [Apresoline]
DrugBank: Hydralazine (DB01275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydralazine (apressine) 50-100 mg
Trial: 6732937
Drug: Endralazine (mirethilan)
RxNorm normalized name: endralazine
DrugBank: Endralazine (DB13435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endralazine (mirethilan) 5-15 mg
Trial: 6732937
Drug: Prazosine (pratsiol)
DrugBank: Prazosin (DB00457)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prazosine (pratsiol) 2-5 mg
Trial: 6732937
Drug: Propranolol (obsidan)
DrugBank: Propranolol (DB00571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propranolol (obsidan) 80-120 mg
Trial: 27112842
Drug: Gonadotropin-releasing hormone
RxNorm normalized name: Gonadotropin-releasing hormone
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gonadotropin-releasing hormone (GnRH; 100 μg IV)
Trial: 25041868
Drug: Intensive intonation‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive intonation‐based speech therapy for 15 weeks
Trial: 25041868
Drug: Intensive intonation‐based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive intonation‐based speech therapy
Trial: 22460943
Drug: rizatriptan 10
RxNorm normalized name: rizatriptan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rizatriptan 10 mg wafer
Trial: 14576536
Drug: 0.56 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.56 mg/kg succinylcholine
Trial: 10588598
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg plus continuing inhaled beclomethasone
Trial: 10588598
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet plus continuing inhaled beclomethasone
Trial: 10588598
Drug: Montelukast 10
RxNorm normalized name: montelukast 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast 10 mg and inhaled placebo
Trial: 10588598
Drug: Placebo tablet
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet and inhaled placebo
Trial: 15167592
Drug: Ketoconazole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole (100 mg/day)
Trial: 2401123
Drug: Oral propafenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral propafenone (300 to 450 mg)
Trial: 2401123
Drug: Intravenous propafenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous propafenone (35 to 50 mg)
Trial: 30121808
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment with paclitaxel plus bevacizumab (2×4 cycles)
Trial: 30121808
Drug: Continuous treatment
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous treatment with paclitaxel plus bevacizumab (8 cycles)
Trial: 30121808
Drug: Intermittent treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent treatment with paclitaxel plus bevacizumab
Trial: 30121808
Drug: Continuous treatment
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous treatment with paclitaxel plus bevacizumab
Trial: 26761213
Drug: Cisplatin with
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin with pemetrexed and concurrent late course accelerated hyperfractionated radiotherapy (LCAHRT)
Trial: 26761213
Drug: Cisplatin with
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin with vinorelbine and concurrent late course accelerated hyperfractionated radiotherapy (LCAHRT)
Trial: 25261187
Drug: Virtual reality
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virtual reality training as an adjunct to conventional therapy
Trial: 25261187
Drug: Dose-matched conventional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose-matched conventional training
Trial: 21054824
Drug: Proton radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton radiation therapy (72 Gy E ± 5%)
Trial: 21054824
Drug: Carbon ion
RxNorm normalized name: CARBON ION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbon ion radiation therapy (63 Gy E ± 5%)
Trial: 16272621
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium supplementation
Trial: 8913468
Drug: Intravenous azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous azithromycin 1 g
Trial: 8913468
Drug: Intravenous azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous azithromycin 2 g
Trial: 8913468
Drug: Intravenous azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous azithromycin 4 g
Trial: 8913468
Drug: Intravenous azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous azithromycin (all doses)
Trial: 1905451
Drug: 6.25 mg
RxNorm normalized name: captopril 6.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6.25 mg irtemazole
Trial: 1905451
Drug: 12.5 mg
RxNorm normalized name: rutin 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12.5 mg irtemazole
Trial: 1905451
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg irtemazole
Trial: 1905451
Drug: 37.5 mg
RxNorm normalized name: pemoline 37.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 37.5 mg irtemazole
Trial: 6132891
Drug: pindolol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pindolol (15 mg daily)
Trial: 6132891
Drug: acebutolol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: acebutolol (500 mg daily)
Trial: 6132891
Drug: acebutolol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: acebutolol (500 mg daily) after 16 months
Trial: 27510655
Drug: Colonic administration
RxNorm normalized name: colonial bent grass pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colonic administration of 13C-labelled acetate
Trial: 27510655
Drug: Colonic administration
RxNorm normalized name: colonial bent grass pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colonic administration of 13C-labelled propionate
Trial: 27510655
Drug: Colonic administration
RxNorm normalized name: colonial bent grass pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colonic administration of 13C-labelled butyrate
Trial: 26717861
Drug: Carvedilol 6.25mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol 6.25mg, twice daily during the run-in period
Trial: 24980672
Drug: Aliskiren 150
RxNorm normalized name: aliskiren 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aliskiren 150 mg once daily (n=9)
Trial: 24980672
Drug: Ramipril 5
RxNorm normalized name: ramipril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril 5 mg once daily (n=7)
Trial: 24980672
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Aliskiren and Ramipril)
Trial: 18987057
Drug: High-dose bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose bupivacaine (Control)
Trial: 14871429
Drug: CsA trough
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CsA trough levels lower than 300 ng/mL
Trial: 12238832
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg tranexamic acid (TA) followed by infusion of 1 mg/kg per hour during the operation
Trial: 7977174
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg p.o. 1 hour prior to chemotherapy, repeated after 6 and 12 hours plus dexamethasone 20 mg i.v. 40 minutes prior to chemotherapy
Trial: 7977174
Drug: High-dose metoclopramide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose metoclopramide, dexamethasone, and orphenadrine (Control)
Trial: 7977174
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg PO t.i.d. days 2 and 3
Trial: 7977174
Drug: Metoclopramide 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide 0.5 mg/kg p.o. q.i.d. and dexamethasone 8 mg i.m. b.i.d. days 2 and 3 (Control)
Trial: 27316489
Drug: 50mg/kg of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50mg/kg of magnesium sulfate (MS) in 100ml 0.9% NaCl solution over 20min before anesthesia induction (Group A)
Trial: 27316489
Drug: 100ml 0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100ml 0.9% NaCl solution (Group B)
Trial: 26353411
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (500 mg day(-1))
Trial: 22625877
Drug: Gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil 600 mg every 12 h for 4 days with a single 15 mg dose of pioglitazone on day 3
Trial: 22625877
Drug: Pioglitazone alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone alone (15 mg)
Trial: 15905227
Drug: Oral protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral protein preload plus ID saline perfusion
Trial: 15905227
Drug: Oral protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral protein preload plus ID fat perfusion
Trial: 10399449
Drug: ICU group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICU group (preoperative treatment aiming at a CI >= 4.0 l/min/m2)
Trial: 12536625
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no special treatment)
Trial: 2076441
Drug: Vancomycin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vancomycin (4 drops of a 5% solution every 8 hours)
Trial: 2076441
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no local treatment)
Trial: 7033789
Drug: D-penicillamine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-penicillamine (250 mg four times a day)
Trial: 28682725
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution gauze (NSS group)
Trial: 18083374
Drug: Chemotherapeutic drugs,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapeutic drugs, immunostimulants, and various vaccines
Trial: 16702472
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (CEE; 0.625 mg)
Trial: 9832936
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg nicotine
Trial: 9832936
Drug: 0.25 mg
RxNorm normalized name: biotin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg nicotine
Trial: 9832936
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg nicotine
Trial: 9832936
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg nicotine